Intranasal Dexamedotomidine Vs intranasal Midazolam in pediatric patients undergoing transcatheter ventricular septal defect (VSD) closure

Authors
Category Primary study
Registry of TrialsPan African Clinical Trials Registry
Year 2023
INTERVENTION: Intranasal dexmedetodine intranasal midazolam CONDITION: ; Paediatrics ; Cardiology Cardiology Paediatrics PRIMARY OUTCOME: faster induction of anesthesia good sedation , Ramsay scale, child parent separation score SECONDARY OUTCOME: maintained hemodynamics recovery state INCLUSION CRITERIA: Children of either se Xwith age ranging from 3 to 12 years old Children with simple congenital heart disease (VSD) undergoing elective cardiac catheterization No coexisting cardiac/medical problems Normal Lab investigations results
Epistemonikos ID: 637ed4a283cd8aad4268ff47b949cb8c129bbff1
First added on: Feb 20, 2024